The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Restoring Balance: What the FDA's Peptide Announcement Could Mean for Patient Access and Safety Empower Pharmacy BPC 157: Regenerative Properties for Tendon & Joint Health Beautox Bar LLC posted on the topic LinkedIn FDA takes first step in possible reversal of ban on some peptides The Washington Post The Basics Behind BPC 157 Injections and Their Effectiveness Your Health Magazine The FDA has sent 30 warning letters to telehealth companies for falsely marketing compounded GLP 1s, which are not FDA approved and can pose risks to patients. FULL STORY:https: tinyurl.com 3ztf9uj2